In this three-part activity, experts discuss the clinical challenges associated with the diagnosis and management of Lennox-Gastaut syndrome (LGS). Topics addressed in this activity include a discussion of the clinical characteristics, epidemiology, and etiology of this epileptic encephalopathy. The current criteria for the diagnosis of LGS are also reviewed. The practical applications of recent data on pharmacologic and nonpharmacologic treatment options are also considered.
Upon completion of this activity, participants should be better able to:
This activity has been designed to meet the educational needs of pediatric neurologists and other healthcare professionals involved in the management of Lennox-Gastaut syndrome.
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
In accordance with ACCME requirements, the University of Florida College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Diego A. Morita, MD Director, New-Onset Seizure Program Cincinnati Children’s Hospital Medical Center Assistant Professor of Pediatrics and Neurology University of Cincinnati College of Medicine Cincinnati, Ohio
Diego A. Morita, MD, currently has no financial interests/relationships or affiliations in relation to this activity.
Jason S. Doescher, MD Pediatric Neurologist and Epileptologist Minnesota Epilepsy Group St. Paul, Minnesota
Jason S. Doescher, MD, has a financial interest/relationship or affiliation in the form of: Speakers Bureau participant with GlaxoSmithKline.
Katherine Holland, MD, PhD Associate Professor of Pediatrics and Neurology Cincinnati Children's Hospital Medical Center University of Cincinnati College of Medicine Cincinnati, Ohio
Katherine Holland, MD, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.
James M. Smith, MD Clinical Assistant Professor and Program Director Department of Internal Medicine University of Florida College of Medicine Gainesville, Florida
James M. Smith, MD, currently has no financial interests/relationships or affiliations in relation to this activity.
Kirk A. Tacka, PhD PVI, PeerView Institute for Medical Education
Kirk A. Tacka, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Florida College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity is jointly sponsored by the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education.
This activity is supported by educational grants from
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
All contents copyright © 2000-, PeerView Press. All rights reserved.
